CRL vs LWACW · rev $4.02B vs $217.7M cap
Charles River Laboratories (CRL) versus LightWave Acquisition Corp. Warrants (LWACW) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
LightWave Acquisition Corp. Warrants (LWACW) common stock listed on NASDAQ.
Latest reported CRL revenue for 2025-12-27 was $4.02B. Net income was -$144.3M. CRL currently screens at market cap $7.78B.
LWACW does not have a complete income-statement cache yet.
CRL currently screens at market cap $7.78B. LWACW currently screens at market cap $217.7M.
Not investment advice. Open the CRL and LWACW stock pages for the full models.
Not investment advice.